RSS

RWBYF Red White & Bloom Brands Inc.

Last Post: 06/02/22
Followers: 1
Posts Today: 0
Views Today: 382

RWBYF Stock Quote & Tools

RWBYF Stock Message Board Discussion

Top 10 Most Recent News Articles

Vertiv's Explosive Q3 Growth: A 2026 Power Move

Updated Category News Views 81

Vertiv's Third Quarter Triumph Imagine a company blowing past expectations like a hot knife through butter—yeah, that's Vertiv for you in 2026. These guys didn’t just ride the wave; they created a tsunami in the digital infrastructure sector. Net sales ballooned by a staggering 61% compared to last year's same quarter, pulling in $4.313 billion. When you consider the...

Continue Reading
Infoya Surges with 665% Growth, Wins Fast 50 Spot

Updated Category News Views 102

From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...

Continue Reading
Heritage Wines Meet Non-Alcoholic Trend: New Deal

Updated Category News Views 84

Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...

Continue Reading
ESI Motion's Role in Lockheed's Missile Defense Program

Updated Category News Views 56

ESI Motion's Solar Drive Tech Joins the Defense Arena Picture this: ESI Motion Inc. just inked a deal with Lockheed Martin to supply Solar Array Drive Electronics (SADE) technology—a serious move in space tech. Now, ESI isn't just playing in the local Simi Valley sandbox; they're thrusting their tech into something much more critical—national defense. We're talking...

Continue Reading
MetaOptics Bolsters Strategies with Buy-Back Mandate

Updated Category News Views 34

Strategic Moves by MetaOptics If you thought the optics game was settled ages ago, think again. Today, MetaOptics Ltd (Catalist: 9MT), from sunny Singapore, is stirring up the pot with their latest game plan—a freshly minted Share Buy-Back Mandate. Shareholders at their general meeting were all thumbs up, and that's no surprise given what's on the table. Aim for...

Continue Reading
Tribal Tech Triumph: ILINX Boosts Proposal Efficiency

Updated Category News Views 77

A New Era for Tribal Operations Well, here's a headline that might've slipped under your radar, but it’s got some serious implications. Over in Olympia, Washington, ImageSource, Inc., the brains behind the ILINX platform, just scored a home run with an automated system for crafting Tribal Indirect Cost Rate Proposals (ICRPs). This ain't just gadget talk; this is a...

Continue Reading
Smartpress: Adobe & Canva Shape Print Design World

Updated Category News Views 115

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Continue Reading
Brokerage Trade Volumes Spike Amid Market Shifts

Updated Category News Views 56

Trading Freight Train Gains Speed Trading is on the upswing, my friends. What good ol' intuition and the headlines tell us, numbers reflect: more retail investors are jumping into the fray, and the brokers are soaking it up. We're eyeing some hefty figures, like a market swell from $11.97 billion in 2025 to a projected $18.29 billion by 2030. That's an 8.9% growth...

Continue Reading
Doximity Faces Legal Heat: 23% Stock Plunge Analyzed

Updated Category News Views 12

Doximity's Rollercoaster: Steep Drop Amid Lawsuits Imagine watching your portfolio take a gut-wrenching plunge—and that's the rollercoaster ride Doximity investors experienced. On May 14, 2026, Doximity's stock nosedived by 23%, closing at $18.01 per share. This tumble, which marked a painful conclusion to a series of financial disappointments, has thrown the company...

Continue Reading

Top 5 Most Recently Viewed Articles

BCMGlobal Takes Charge of NFSC's Loan Servicing Evolution

Updated Category News Views 197

BCMGlobal's New Role in Advancing NFSC BCMGlobal has been appointed to strategically manage the National Financing Support Services Company (NFSC), elevating it to a leading independent loan servicer. This initiative aims to promote excellence in the sector. Supporting Saudi Arabia's Financial Vision The NFSC, established with the backing of the Saudi Real Estate...

Continue Reading
Breakthrough MRD Data from Myriad Genetics at Cancer Conference

Updated Category News Views 201

Innovative Insights into MRD Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent name in molecular diagnostics and precision medicine, is set to unveil exciting new clinical findings related to their Precise MRD test at a significant annual meeting dedicated to cancer research. Presentation Highlights During the conference, Dr. Chad Tang from The University of Texas...

Continue Reading
SBM Offshore's Recent Share Buyback Program: Key Insights

Updated Category News Views 119

SBM Offshore's Share Buyback Program Overview SBM Offshore has recently reported on its significant share repurchase program, valued at EUR130 million (approximately US$140 million), covering transactions made from November 21, 2024, to November 27, 2024. This initiative underscores the company’s commitment to enhancing shareholder value through systematic buybacks. Key...

Continue Reading
Investigation into Akero Therapeutics by Berger Montague PC

Updated Category News Views 165

Akero Therapeutics Under Investigation by Berger Montague Berger Montague PC, a respected law firm, recently brought to attention an ongoing investigation into the practices of Akero Therapeutics, Inc. The investigation focuses on potential breaches of fiduciary duties and violations of federal securities laws by Akero’s Board of Directors, which has crucial...

Continue Reading
Nkarta's Upcoming Interactive Session: What to Expect?

Updated Category News Views 127

Nkarta to Engage with Investors in H.C. Wainwright Series Nkarta, Inc. (NASDAQ: NKTX), a pioneering clinical-stage biopharmaceutical firm dedicated to creating innovative engineered natural killer (NK) cell therapies, recently announced its notable role in the H.C. Wainwright "HCW@Home" Series. This virtual series will allow investors and interested parties to gain deeper...

Continue Reading